Back to Search
ERIC WINER, MD
MD
Hematology & Oncology Physician
NPI: 1609852516IndividualAccepts Medicare
Specialties, Licenses & Credentials
Hematology & Oncology PhysicianPrimary
Internal Medicine — Hematology & Oncology
Code: 207RH0003X
213276(MA)
Education
UNIVERSITY OF NORTH CAROLINA AT CHAPEL HILL SCHOOL OF MEDICINE
Class of 1999
Research & Publications (20)
The optimal duration of adjuvant hormonal therapy for early-stage breast cancer.
PMID 18820598·Clin Adv Hematol Oncol·2008
6-review
Endocrine and targeted manipulation of breast cancer: summary statement for the Sixth Cambridge Conference.
PMID 18072254·Cancer·2008
8-other
Summary of aromatase inhibitor clinical trials in postmenopausal women with early breast cancer.
PMID 18072256·Cancer·2008
8-other
Case records of the Massachusetts General Hospital. Case 32-2007. A 62-year-old woman with a second breast cancer.
PMID 17942877·N Engl J Med·2007
5-case
American Society of Clinical Oncology technology assessment on the use of aromatase inhibitors as adjuvant therapy for postmenopausal women with hormone receptor-positive breast cancer: status report 2004.
PMID 15545664·J Clin Oncol·2005
6-review
GM-CSF and low-dose cytosine arabinoside in high-risk, elderly patients with AML or MDS.
PMID 15934494·Oncology (Williston Park)·2005
8-other
Failure of higher-dose paclitaxel to improve outcome in patients with metastatic breast cancer: cancer and leukemia group B trial 9342.
PMID 15169793·J Clin Oncol·2004
3-trial
New combinations with Herceptin in metastatic breast cancer.
PMID 11694788·Oncology·2001
4-observational
Adjuvant chemotherapy in older women with early-stage breast cancer.
PMID 19439741·N Engl J Med·2009
4-observational
Topoisomerase II{alpha} amplification does not predict benefit from dose-intense cyclophosphamide, doxorubicin, and fluorouracil therapy in HER2-amplified early breast cancer: results of CALGB 8541/150013.
PMID 19470942·J Clin Oncol·2009
8-other
ALK-positive diffuse large B-cell lymphoma: report of four cases and review of the literature.
PMID 19250532·J Hematol Oncol·2009
5-case
Racial differences in definitive breast cancer therapy in older women: are they explained by the hospitals where patients undergo surgery?
PMID 19536008·Med Care·2009
4-observational
Phase I study of nonpegylated liposomal doxorubicin plus trastuzumab in patients with HER2-positive breast cancer.
PMID 19433391·Clin Breast Cancer·2009
3-trial
Tolerability of and adherence to combination oral therapy with gefitinib and capecitabine in metastatic breast cancer.
PMID 19294501·Breast Cancer Res Treat·2009
3-trial
A comparative study of exemestane versus anastrozole in patients with postmenopausal breast cancer with visceral metastases.
PMID 19299239·Clin Breast Cancer·2009
4-observational
A collaborative interaction and visualization multi-modal environment for surgical planning.
PMID 19377123·Stud Health Technol Inform·2009
8-other
Nonengraftment haploidentical cellular immunotherapy for refractory malignancies: tumor responses without chimerism.
PMID 19285629·Biol Blood Marrow Transplant·2009
3-trial
Three-dimensional segmentation of tumors from CT image data using an adaptive fuzzy system.
PMID 19647818·Comput Biol Med·2009
8-other
International guidelines for management of metastatic breast cancer: combination vs sequential single-agent chemotherapy.
PMID 19657108·J Natl Cancer Inst·2009
6-review
Impact of a mixed strength and endurance exercise intervention on levels of adiponectin, high molecular weight adiponectin and leptin in breast cancer survivors.
PMID 19434504·Cancer Causes Control·2009
2-rct
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 450 BROOKLINE AVE
BOSTON, MA 02215 - Phone
- (617) 632-2053
Quick Facts
- NPI
- 1609852516
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 1
- Years in Practice
- 27
- Publications
- 20
Are you this provider?
Claim Your Profile